Down-regulation of Sphk2 suppresses bladder cancer progression

Cancer statistics, 2013

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Hans von der Maase, Lisa Sengeløv, J.T. Roberts et al. · Journal of Clinical Oncology · 2005 · 1.9K citations

Medicine, Oncology, Urology +6

The present and future burden of urinary bladder cancer in the world

Martine Ploeg, Katja K.H. Aben, Lambertus A. Kiemeney · World Journal of Urology · 2009 · 923 citations · Full text

Medicine, Oncology, Urology +16

Discovery and evaluation of inhibitors of human sphingosine kinase.

Kevin J. French, Randy S. Schrecengost, Brian D. Lee et al. · PubMed · 2003 · 600 citations

Medicine, Oncology, Pharmacology +10

Sphingosine Kinase 2 Is a Nuclear Protein and Inhibits DNA Synthesis

Nobuaki Igarashi, Taro Okada, Shun Hayashi et al. · Journal of Biological Chemistry · 2003 · 411 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15